Bristol-Myers Squibb Company Common Stock (BMY)
sell disclosed on 26 Dec 2022 via House STOCK Act disclosures
- Transaction value
- US$100,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- Not available
Public insider research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Insider research history
Nicholas V. Taylor
Public disclosure history for this insider, with previous signal outcomes and source links kept visible for research review.
9 disclosures
0 buys
9 sells
30d outcome not resolved yet
Insider facts
- Role
- Representative
- Country
- US
- Type
- POLITICIAN
- Repeat disclosures
- 0
Related companies
Bristol-Myers Squibb Company Common Stock (BMY)
BMY, US, 1 disclosure
Chevron Corporation Common Stock (CVX)
CVX, US, 1 disclosure
Eli Lilly and Company Common Stock (LLY)
LLY, US, 1 disclosure
Exxon Mobil Corporation Common Stock (XOM)
XOM, US, 1 disclosure
Moody's Corporation Common Stock (MCO)
MCO, US, 1 disclosure
Occidental Petroleum Corporation Common Stock (OXY)
OXY, US, 1 disclosure
Santos, Ltd. Unsponsored ADR (SSLTY)
SSLTY, US, 1 disclosure
Zimmer Biomet Holdings, Inc. Common Stock (ZBH)
ZBH, US, 1 disclosure
ZimVie Inc. (ZIMV)
ZIMV, US, 1 disclosure
Politician review
Historical research metrics from promoted public disclosures only. This is not investment advice.
93% avg. data confidence
- Hypothetical 30d win rate
- 0 of 0 positive outcomes
- Best reviewed outcome
- No outcome
- Weakest reviewed outcome
- No outcome
Repeated sectors
- Unclassified, 9 disclosures
Repeated companies
No repeated companies yet.
Disclosure history
Chevron Corporation Common Stock (CVX)
sell disclosed on 26 Dec 2022 via House STOCK Act disclosures
- Transaction value
- US$500,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- Not available
Eli Lilly and Company Common Stock (LLY)
sell disclosed on 26 Dec 2022 via House STOCK Act disclosures
- Transaction value
- US$1,000,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- Not available
Exxon Mobil Corporation Common Stock (XOM)
sell disclosed on 26 Dec 2022 via House STOCK Act disclosures
- Transaction value
- US$1,000,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- Not available
Moody's Corporation Common Stock (MCO)
sell disclosed on 26 Dec 2022 via House STOCK Act disclosures
- Transaction value
- US$250,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- Not available
Occidental Petroleum Corporation Common Stock (OXY)
sell disclosed on 26 Dec 2022 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- Not available
Santos, Ltd. Unsponsored ADR (SSLTY)
sell disclosed on 26 Dec 2022 via House STOCK Act disclosures
- Transaction value
- US$15,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- Not available
Zimmer Biomet Holdings, Inc. Common Stock (ZBH)
sell disclosed on 26 Dec 2022 via House STOCK Act disclosures
- Transaction value
- US$100,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- Not available
ZimVie Inc. (ZIMV)
sell disclosed on 26 Dec 2022 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- Not available